Nuvance Health offers breast cancer surgical technique that reduces side effects from surgery
August 8, 2022
“We can now greatly reduce a patient’s risk of developing lymphedema after a mastectomy to treat DCIS because we do not need to remove lymph nodes at the time of the original surgery,” said Dr. Susan K. Boolbol, system chief of breast surgical oncology and breast program at Nuvance Health.
Learn why Nuvance Health recently adopted the Magtrace® Lymphatic Tracer and how the technology has opened doors to innovative procedures, making a difference in patients’ lives.
Click here to read the full story.